MEGAN GREMBAN: Open Payments
NPI 1295166601 · GRAND RAPIDS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,603 in 56 payments from 15 companies in 2025. Trend: 2023 $1,726 · 2024 $1,466 · 2025 $1,603
Food & beverage: $1,508Education: $95
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $308 |
| Janssen Biotech, Inc. | 3 | $241 |
| UCB, Inc. | 5 | $185 |
| Incyte Corporation | 6 | $155 |
| Arcutis Biotherapeutics, Inc. | 4 | $144 |
| Organon LLC | 8 | $111 |
| GENZYME CORPORATION | 3 | $99 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $79 |
| E.R. Squibb & Sons, L.L.C. | 2 | $78 |
| Regeneron Healthcare Solutions, Inc. | 2 | $78 |
Products named: TREMFYA, Bimzelx, RINVOQ, DUPIXENT, OPZELURA, SKYRIZI, Zoryve, SPEVIGO.
Industry payments across MI — which companies pay providers there.
